Utility of newly developed short-type double-balloon endoscopy for endoscopic retrograde cholangiography in postoperative patients
Utility of newly developed short-type double-balloon endoscopy for endoscopic retrograde cholangiography in postoperative patients
复制标题
DOI：
10.1111/jgh.13713
复制
发表时间：
2017-07-01
影响因子：
4.1
通讯作者：
Okazaki, Kazuichi
中科院分区：
文献类型：
--
作者：
Shimatani, Masaaki;Tokuhara, Mitsuo;Okazaki, Kazuichi
背景和目的传统的短型双气囊内镜（DBE）在胰胆管疾病术后解剖患者中的实用性已被广泛认可和接受。然而，仍然存在一些技术困难。为了解决这些问题，新型短型DBE（N-short DBE）被独特地设计用于术后患者的治疗性内窥镜逆行胆管造影（ERC）。本研究的目的是评估N-short DBE用于ERC在术后patients.MethodsFrom 2015年8月至2016年4月，ERC使用N-short DBE（DB-ERC）进行了100例术后患者（112个程序）。我们回顾性研究了达到盲端的成功率，达到盲端的中位时间，诊断成功率，治疗成功率，完成ERC相关干预的中位时间，总体成功率，完成DB-ERC的中位时间，和不良事件。到达盲端的中位时间为10 min（四分位距[IQR]，6- 19 min）。诊断成功率为98.2%。治疗成功率100%。完成ERC相关干预的中位时间为36分钟（IQR，22- 62分钟）。DB-ERC的总体成功率为97.3%。完成DB-ERC的中位时间为54 min（IQR，37- 73 min）。不良反应发生率为2.7%。DB-ERC是此类患者有前途的治疗方式，应被选为一线政策。
Background and AimThe utility of conventional short-type double-balloon endoscopy (DBE) for pancreatobiliary disease in patients with postoperative anatomy had been widely acknowledged and accepted. However, some technical difficulties yet remained. In an attempt to solve these problems, the new short-type DBE (N-short DBE) was uniquely designed for therapeutic endoscopic retrograde cholangiography (ERC) in postoperative patients. The aim of this study was to evaluate the usefulness of N-short DBE for ERC in postoperative patients.MethodsFrom August 2015 to April 2016, ERC using N-short DBE (DB-ERC) was performed in 100 postoperative patients (112 procedures). We retrospectively studied the success rate of reaching the blind end, the median time to reach the blind end, the diagnostic success rate, the therapeutic success rate, the median time to complete ERC-related interventions, the overall success rate, the median time to complete DB-ERC, and adverse events.ResultsThe success rate of reaching the blind end was 99.1%. The median time to reach the blind end was 10min (interquartile range [IQR], 6-19min). The diagnostic success rate was 98.2%. The therapeutic success rate was 100%. The median time to complete ERC-related interventions was 36min (IQR, 22-62min). The overall DB-ERC success rate was 97.3%. The median time to complete DB-ERC was 54min (IQR, 37-73min). The occurrence of adverse events was 2.7%.ConclusionsThe N-short DBE for ERC in postoperative patients is useful and safe. DB-ERC is promising therapeutic modality in such patients and should be selected as the first-line policy.